Chemical modification of birch allergen extract leads to a reduction in allergenicity as well as immunogenicity

Background: In Europe, specific immunotherapy is currently conducted with vaccines containing allergen preparations based on intact extracts. In addition to this, chemically modified allergen extracts (allergoids) are used for specific allergy treatment. Reduced allergenicity and thereby reduced risk of side effects in combination with retained ability to activate T cells and induce protective allergen-specific antibody responses has been claimed for allergoids. In the current study, we compared intact allergen extracts and allergoids with respect to allergenicity and immunogenicity. Methods: The immunological response to birch allergen extract, alum-adsorbed extract, birch allergoid and alum-adsorbed allergoid was investigated in vitro in human basophil histamine release assay and by stimulation of human aller-gen-specific T cell lines. In vivo, Bet v 1- specific lgG titers in mice were determined after repetitive immunizations. Results: In all patients tested ( n = 8), allergoid stimulations led to reduced histamine release compared to the intact allergen extract. However, the allergoid preparations were not recognized by Bet v 1- specific T cell lines ( n = 7), which responded strongly to the intact allergen extract. Mouse im-munizations showed a clearly reduced lgG induction by allergoids and a strongly potentiating effect of the alum adjuvant. Optimal lgG titers were obtained after 3 immunizations with intact allergen extracts, while 5 immunizations were needed to obtain maximal response to the allergoid. Conclusion: The reduced histamine release observed for allergoid preparations may be at the expense of immunological efficacy because the chemical modifications lead to a clear reduction in T cell activation and the ability to induce allergen-specific lgG antibody responses. Copyright (C) 2007 S. Karger AG, Basel